NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
44 hedge funds and large institutions have $13.4M invested in NexImmune, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 17 closing their positions.
15% less funds holding
Funds holding: 52 → 44 (-8)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
62% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 13
67% less capital invested
Capital invested by funds: $40.1M → $13.4M (-$26.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KHCM
Kettle Hill Capital Management
New York
|
+$675K |
| 2 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$495K |
| 3 |
Millennium Management
New York
|
+$449K |
| 4 |
E
Ergoteles
New York
|
+$213K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$105K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.93M |
| 2 |
JP Morgan Chase
New York
|
-$1.07M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$679K |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$497K |
| 5 |
State Street
Boston,
Massachusetts
|
-$473K |
NEXI Hedge Fund Activity: Q2 2022 in Review
44 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2022, worth a combined $13.4M — down 67% from $40.1M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of NEXI and 11 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 5 added.
The largest buyer was Kettle Hill Capital Management, opening a new position worth an estimated $675K. The largest seller was BlackRock, cutting an estimated $1.93M.
- 44 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2022, down from 52 in Q1 2022.
- Funds reported $13.4M of NexImmune, Inc. Common Stock stock for Q2 2022, down 67% quarter-over-quarter.
- 11 funds opened new NexImmune, Inc. Common Stock positions in Q2 2022 and 17 closed out, a net change of -6 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q2 2022 was Kettle Hill Capital Management, an estimated $675K added.
- The largest NexImmune, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $1.93M sold.
Based on aggregated 13F filings for Q2 2022.